An observational study in Holistic Care, Mental Health and Sleep, sponsored by Baylor University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-03-10.
Sponsored by Baylor University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States — 340 open to participants now, 403 under way, 18 of them phase 3. Stress Disorders, Post-Traumatic · United States.
Among the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States, this one is the 102nd largest by planned enrollment of the 165 observational ones that give a count, is one of 97 that started in 2026, is one of 166 observational ones, reaches primary completion later than 97 of the 402 other live ones, and was the 1,569th registered.
2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.
Browse Stress Disorders, Post-Traumatic studies →340 of the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States are open now. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 18–55
University of Michigan · Sites in United States
Ages 18+ · Women only
Summit Hyperbarics and Wellness · Sites in United States
Ages 18–75
Anthony Vesco · Sites in United States
Ages 8–18
Transcend Therapeutics · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,664 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 132 · Phase 2 234 · Phase 3 95 · Phase 4 90
First in 1991; this study’s year is marked. 97 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 150 across 371 observational studies indexed under Stress Disorders, Post-Traumatic.
Median enrollment 65 across the 1,491 interventional studies, 107 across the 165 observational. Of the 1,137 that completed or were terminated, 491 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
98 of 1,664 have an industry lead sponsor. The 10 most frequent:
Baylor University is the lead sponsor of 42 studies on the registry; 9 are open to participants now.
Baylor University has 2 studies filed under Stress Disorders, Post-Traumatic — fewer than ten, so there is no comparison to draw.
154 of the studies in Stress Disorders, Post-Traumatic with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06117306Phase 3Healing BreakthroughMDMA-assisted Massed Prolonged Exposure for PTSD | 2027-03 |
| NCT04877093Phase 3Wake Forest University Health SciencesRepurposing Low-Dose Clonidine for PTSD in Veterans | 2027-03-31 |
| NCT06273527Phase 3University of California, San DiegoEnhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) | 2027-06-01 |
| NCT07217795University of Rhode IslandRecovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building | 2026-11 |
| NCT04585685Christal L BadourHealthy Recovery After Trauma Study | 2026-11 |
Add all 154 to your calendar (.ics) → With an account.
Among the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate outcomes from the Shields \& Stripes (S\&S) program - a 12-week, multidisciplinary wellness intervention designed for veterans and first responders. The S\&S program integrates occupational therapy (OT), mental health (MH), physical therapy (PT), and registered dietitian (RD) services to promote recovery, resilience, and performance in individuals who have experienced cumulative stress, trauma exposure, or occupational burnout.
This research will use a retrospective mixed-methods observational design to analyze data collected from previous S\&S participants who consent to research use of their de-identified information. No intervention or treatment changes will occur as part of this study.
Quantitative data will include biometric information (e.g., sleep, activity, and heart rate variability via Oura Ring), standardized self-report measures (GAD-7, PHQ-9, PCL-5, RAND-36, PSQI, ISI), satisfaction surveys, and laboratory nutrition panels. Qualitative data will include semi-structured interviews with consenting participants and S\&S providers following program completion.
The purpose of the study is to identify patterns of improvement in physical, psychological, and occupational functioning and to explore how integrated, team-based care supports holistic recovery. Findings may inform the development of future evidence-based wellness programs for military and first-responder populations.
Participation involves minimal risk, and all data will be de-identified before analysis.
Study Overview This retrospective mixed-methods observational study evaluates the effectiveness of the Shields \& Stripes (S\&S) program, a 12-week integrated wellness model that combines occupational therapy (OT), mental health (MH) services, physical therapy (PT), and registered dietitian (RD) support. The program serves veterans and first responders who experience cumulative physical, cognitive, and emotional stress related to their service.
The study will retrospectively analyze quantitative and qualitative data from S\&S cohorts between 2024-2026 to assess changes in health, functioning, and quality of life.
Objectives
Evaluate changes in physical, psychological, and occupational functioning following participation in S\&S.
Explore relationships between biometric indicators (e.g., heart-rate variability, sleep, activity) and self-reported well-being.
Examine trends in nutrition and metabolic markers across cohorts.
Analyze participant and provider perspectives through qualitative interviews to better understand mechanisms of change and perceived program value.
Design and Methods
Design: Convergent mixed-methods retrospective observational study.
Quantitative Data: Includes biometric data (sleep, HRV, activity), self-report scales (GAD-7, PHQ-9, PCL-5, RAND-36, PSQI, ISI), and laboratory measures (cholesterol, glucose regulation, vitamin D, testosterone, thyroid, inflammatory markers, etc.).
Qualitative Data: Semi-structured interviews with consenting participants and providers conducted post-program (via teleconference).
Participants: Veterans and first responders aged 18-70 who have completed the S\&S program and program providers who have worked within the S\&S program.
Recruitment: No direct external recruitment will occur for this study. All participants will be drawn from existing Shields \& Stripes program cohorts and affiliated program providers, which utilize processes separate from this research.
Data Handling: All data will be de-identified prior to analysis; stored securely on encrypted, access-restricted cloud servers.
Primary Outcomes
Change in self-reported anxiety (GAD-7)
Change in depressive symptoms (PHQ-9)
Change in PTSD symptoms (PCL-5)
Change in sleep (PSQI and ISI)
Change in quality of life (RAND-36)
Change in sleep quality and recovery metrics (Oura Ring data)
Secondary Outcomes
Changes in nutritional and metabolic lab results (e.g., cholesterol, glucose, vitamin D, thyroid function).
Qualitative themes related to perceived program benefit, barriers, and provider perspectives.
Duration and Setting Data will be collected retrospectively from cohorts between 2024-2026. The study will take place remotely with data stored and analyzed by the research team.
Risk and Safeguards The study is minimal risk. No interventions or procedures are performed beyond standard program participation. Risks are limited to potential discomfort during interviews and minimal risk of confidentiality breach, mitigated through HIPAA-compliant data handling.
Expected Impact Results will inform how multidisciplinary programs combining OT, MH, PT, and RD services improve functional, psychological, and physiological outcomes among high-stress occupational populations. The study aims to contribute to the evidence base for integrated, holistic wellness approaches for veterans and first responders.
2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.
This study's planned enrollment of 80 is below the median of 150 across 371 observational studies indexed under Stress Disorders, Post-Traumatic.
Browse Stress Disorders, Post-Traumatic studies →Baylor University is the lead sponsor of 42 studies on the registry; 9 are open to participants now.
Compared within Stress Disorders, Post-Traumatic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The study population consists of U.S. military veterans and first responders who have participated in the Shields \& Stripes 12-week multidisciplinary wellness program. The program integrates occupational therapy, mental health, physical therapy, and nutrition services. All data analyzed will be collected post-program completion, making the study primarily retrospective.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-None
Participants include veterans and first responders who have completed the 12-week Shields \& Stripes holistic wellness program. The program integrates occupational therapy, mental health, physical therapy, and registered dietitian services to address physical, psychological, and occupational functioning. Data analyzed for this study include de-identified biometric, psychological, and laboratory outcomes collected as part of standard program procedures. Past and present program providers will also serve as participants to gain a better understanding of the program and its impact. No additional interventions are introduced for research purposes.
Change in Psychological Functioning Generalized Anxiety Disorder 7-item (GAD-7) scale
To assess changes in anxiety symptoms before and after participation in the 12-week Shields \& Stripes program using validated self-report measures. Score range: 0 to 21 Higher scores indicate: Worse anxiety symptoms
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Psychological Functioning utilizing Patient Health Questionnaire-9 (PHQ-9)
To assess changes in depression symptoms before and after participation in the 12-week Shields \& Stripes program using validated self-report measures. Score range: 0 to 27 Higher scores indicate: Worse depressive symptoms
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Psychological Functioning utilizing the Posttraumatic Stress Disorder Checklist (PCL-5)
To assess changes in post-traumatic stress symptoms before and after participation in the 12-week Shields \& Stripes program using validated self-report measures. Score range: 0 to 80 Higher scores indicate: Worse PTSD symptoms
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Heart Rate Variability (HRV)
Change in heart rate variability as measured by the Oura Ring wearable device. HRV will be reported as the nightly average root mean square of successive differences (RMSSD). Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Milliseconds (ms) Directionality: Higher values indicate better autonomic nervous system balance and recovery.
Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)
Change in Sleep Quality - Pittsburgh Sleep Quality Index (PSQI)
Change in sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI), a validated 19-item self-report questionnaire assessing sleep quality and disturbances over the past month. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: Total PSQI global score (range: 0 to 21) Directionality: Higher scores indicate worse sleep quality.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Health-Related Quality of Life - RAND 36-Item Health Survey (RAND-36)
Change in health-related quality of life as measured by the RAND 36-Item Health Survey (RAND-36), a validated self-report questionnaire assessing eight domains including physical functioning, role limitations (physical and emotional), energy/fatigue, emotional well-being, social functioning, pain, and general health perceptions. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: RAND-36 subscale scores transformed to a 0-100 scale. Directionality: Higher scores indicate better health-related quality of life and functioning.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Total Cholesterol
Change in total cholesterol measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved lipid profile.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Qualitative Themes from Semi-Structured Interviews
Participant and provider feedback will be collected using a semi-structured interview guide developed for this study. Thematic analysis will identify recurring themes related to participant satisfaction, perceived effectiveness, and experiences with integrated occupational therapy, mental health, physical therapy, and nutrition services. Time Frame: Post-Program (within 4 weeks of completion) Unit of Measure: Not applicable (qualitative thematic analysis)
Time frame: Post-Program (within 4 weeks of completion)
Change in Physical Function and Performance (PSFS)
Change in self-reported physical function measured by the Patient-Specific Functional Scale (PSFS), reflecting improvements in self-identified functional goals and mobility. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: Mean PSFS total score (0-10 scale) Directionality: Higher scores indicate better functional performance
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Sleep Duration
Change in total nightly sleep duration as measured by the Oura Ring wearable device. Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Hours (or minutes - choose one and stay consistent) Directionality: Higher values indicate longer sleep duration
Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)
Change in Sleep Efficiency
Change in sleep efficiency as measured by the Oura Ring wearable device. Sleep efficiency is calculated as the percentage of time in bed spent asleep. Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Percentage (%) Directionality: Higher values indicate better sleep quality.
Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)
Change in Resting Heart Rate
Change in resting heart rate as measured by the Oura Ring wearable device. Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Beats per minute (bpm) Directionality: Lower values generally indicate better cardiovascular fitness and recovery.
Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)
Change in Physical Activity Level
Change in average daily activity level as measured by the Oura Ring wearable device. Unit of Measure: Oura Activity Score (0-100 scale) Directionality: Higher values indicate greater physical activity.
Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)
Change in Insomnia Severity - Insomnia Severity Index (ISI)
Change in insomnia symptom severity as measured by the Insomnia Severity Index (ISI), a validated 7-item self-report questionnaire assessing perceived insomnia severity. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: Total ISI score (range: 0 to 28) Directionality: Higher scores indicate more severe insomnia symptoms.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in HDL Cholesterol
Change in high-density lipoprotein (HDL) cholesterol measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Higher values indicate improved lipid profile.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in LDL Cholesterol
Change in low-density lipoprotein (LDL) cholesterol measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved lipid profile.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Triglycerides
Description: Change in triglyceride levels measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved lipid profile.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Fasting Glucose
Description: Change in fasting blood glucose measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved glycemic control.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Hemoglobin A1c (HbA1c)
Description: Change in hemoglobin A1c (HbA1c), a measure of average blood glucose over approximately three months, measured via standard laboratory testing. Unit of Measure: Percent (%) Directionality: Lower values indicate improved glycemic control.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in High-Sensitivity C-Reactive Protein (hs-CRP)
Description: Change in high-sensitivity C-reactive protein (hs-CRP), a biomarker of systemic inflammation, measured via standard laboratory testing. Unit of Measure: mg/L Directionality: Lower values indicate reduced systemic inflammation.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Vitamin D (25-hydroxyvitamin D)
Description: Change in serum 25-hydroxyvitamin D levels measured via standard laboratory testing. Unit of Measure: ng/mL Directionality: Higher values indicate improvement toward normal vitamin D status.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Change in Thyroid Stimulating Hormone (TSH)
Description: Change in thyroid stimulating hormone (TSH) levels measured via standard laboratory testing. Unit of Measure: mIU/L Directionality: Movement toward the normal reference range indicates improved thyroid function.
Time frame: Baseline (Week 0) to Post-Program (Week 12)
Plan to share: No — This study involves retrospective analysis of de-identified data collected from participants in the Shields \& Stripes program. Individual participant data (IPD) will not be shared with other researchers outside the study team. Only aggregated, de-identified results will be reported in publications and presentations.
Start is estimated for Apr 2026; primary completion for Dec 2026, 8 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stress Disorders, Post-Traumatic →
Baylor University